Executive Summary: Market for Generic Biologics: Issues, Trends, and Market Potential, 2nd edition

Kalorama Information Executive Summaries
November 1, 2005
9 Pages - SKU: KLE1198635
PHARMACEUTICAL MARKET INDIA 2014-2020 : Formulations, Active Pharmaceutical Ingredients (APIs), Contract Research and Manufacturing Services (CRAMS), Biosimilars, Generics & Vaccines
8/1/2014 | published by: Kelly Scientific Publications
PHARMACEUTICAL MARKET INDIA 2014-2020, Formulations, Active Pharmaceutical Ingredients (APIs), Contract Research and Manufacturing Services (CRAMS), Biosimilars, Generics & Vaccines “PHARMACEUTICAL MARKET INDIA 2014-2020, Formulations, Active Pharmaceutical Ingredients (APIs), Contract Research and Manufacturing  |  read more...
USD 2,000
Pharmaceuticals and Healthcare Report - China Q3 2014
6/11/2014 | published by: Business Monitor International
China Pharmaceuticals and Healthcare Report Q3 2014 BMI View: In line with our optimism towards the Chinese healthcare sector, many multinational pharmaceutical firms continue to record healthy double-digit revenue growth in Q114, despite the economic  |  read more...
USD 1,295
Pharmaceuticals and Healthcare : Belgium Pharmaceuticals and Healthcare Report Q3 2014
6/4/2014 | published by: Business Monitor International
Pharmaceuticals and Healthcare : Belgium Pharmaceuticals and Healthcare Report Q3 2014 Belgium continues to attract the attention of multinational firms as a European hub for clinical trials, newdrug development and niche research. However, a highly developed  |  read more...
USD 1,295
Pharmaceuticals and Healthcare : Brazil Pharmaceuticals and Healthcare Report Q3 2014
6/4/2014 | published by: Business Monitor International
Pharmaceuticals and Healthcare : Brazil Pharmaceuticals and Healthcare Report Q3 2014 BMI View: The Brazilian pharmaceutical market will continue to be the most attractive to multinationalpharmaceutical companies in Latin America. Strong government support, an improving regulatory  |  read more...
USD 1,295
Pharmaceuticals and Healthcare : Estonia Pharmaceuticals and Healthcare Report Q3 2014
6/4/2014 | published by: Business Monitor International
Pharmaceuticals and Healthcare : Estonia Pharmaceuticals and Healthcare Report Q3 2014 Estonia will continue to present a relatively limited market for pharmaceuticals despite having a positivebusiness environment. The reason for that is limited growth in pharmaceutical  |  read more...
USD 1,295
Pharmaceuticals and Healthcare : France Pharmaceuticals and Healthcare Report Q3 2014
6/4/2014 | published by: Business Monitor International
Pharmaceuticals and Healthcare : France Pharmaceuticals and Healthcare Report Q3 2014 BMI View: Public consumption in France will decline in 2014 and 2015 as the government attempts tobring the fiscal deficit within the EU's deficit reduction  |  read more...
USD 1,295
Pharmaceuticals and Healthcare : Peru Pharmaceuticals and Healthcare Report Q3 2014
6/4/2014 | published by: Business Monitor International
Pharmaceuticals and Healthcare : Peru Pharmaceuticals and Healthcare Report Q3 2014 BMI View: Although per capita medicine spending in Peru is among the lowest in Latin America,pharmaceutical companies can generate rapid sales growth in the country  |  read more...
USD 1,295
Pharmaceuticals and Healthcare : Ukraine Pharmaceuticals and Healthcare Report Q3 2014
6/4/2014 | published by: Business Monitor International
Pharmaceuticals and Healthcare : Ukraine Pharmaceuticals and Healthcare Report Q3 2014 BMI View: Ukraine remains a risky pharmaceutical market, despite having once been one of the mostattractive markets in the Central and Eastern European region. In  |  read more...
USD 1,295
Generic and innovative drugs market in Central Europe 2014 - Comparative analysis, reimbursement policies and development forecasts for 2014-2018
6/1/2014 | published by: PMR
Generic and innovative drugs market in Central Europe 2014 - Comparative analysis, reimbursement policies and development forecasts for 2014-2018 What is the value of the Central European generic and innovative drug market? Report provides comparative analyses, forecasts  |  read more...
USD 3,500
Analyzing the Global Generics Industry 2014
5/1/2014 | published by: Aruvian's R'search
Analyzing the Global Generics Industry 2014 In recent times there has been a growing focus on the generic drugs industry worldwide. The patent expiry of leading drugs in recent  |  read more...
USD 1,750
 

SELECT A LICENSE

    Online Download  USD 500  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!